Frequently bought together

Brand : ETORIA

ETORIA 90/MG FC TAB 28/FC TAB

60.45

Sku : I-014553
Key features
ETORIA 90 mg film-coated tablets contain the active ingredient etoricoxib. It acts as a selective cyclooxygenase-2 (COX-2) inhibitor, reducing prostaglandin synthesis involved in pain and inflammation while sparing COX-1 at therapeutic doses. It is indicated for symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis, for short-term management of acute pain including postoperative dental pain, and for primary dysmenorrhea where locally approved. Available by prescription as film-coated tablets in packs of 28.
- Brand: ETORIA
- Active Ingredient: Etoricoxib
- Strength: 90mg
- Dosage Form: Film-coated tablet
- Pack Size: 28 Tablets
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Analgesic
- Pharmacological Group: COX-2 Inhibitors
- Drug Class: Selective COX-2 Inhibitor (Coxib) NSAID
- Manufacturer: Rovi Pharma Industrial Service
- Country of Origin: Spain
- SFDA Registration No.: 1512211481
- Shelf Life: 36 months
- Storage: do not store above 30°c
- Pain Type: Joint, Muscular
- Nsaid: Yes
- Opioid: No

Frequently bought together

Description

Specification

Indications

Approved Uses

Symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute gouty arthritis; short‑term treatment of acute pain including postoperative dental surgery pain; primary dysmenorrhea (where locally approved).

Off-Label Uses

Chronic low back pain and other musculoskeletal pain syndromes (off‑label depending on jurisdiction); postoperative pain beyond labeled dental surgery indications (off‑label).

Pharmacology

Mechanism of Action

Selective cyclooxygenase‑2 (COX‑2) inhibition, reducing prostaglandin synthesis involved in pain and inflammation, with relatively minimal COX‑1 inhibition at therapeutic doses.